Share of people with HIV who receive antiretroviral therapy in Tajikistan
Tajikistan: Share of people with HIV who receive antiretroviral therapy was 81.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Tajikistan, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
Tajikistan recorded 81.0% for share of people with hiv who receive antiretroviral therapy in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 6.6% on the previous year and up 350.0% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Tajikistan peaked at 81.0% in 2024 and was at its lowest, 0.0%, in 2000.
Tajikistan ranks 49th of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Tajikistan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 1.0% | +0.0% |
| 2008 | 2.0% | +100.0% |
| 2009 | 3.0% | +50.0% |
| 2010 | 5.0% | +66.7% |
| 2011 | 7.0% | +40.0% |
| 2012 | 9.0% | +28.6% |
| 2013 | 12.0% | +33.3% |
| 2014 | 18.0% | +50.0% |
| 2015 | 26.0% | +44.4% |
| 2016 | 33.0% | +26.9% |
| 2017 | 40.0% | +21.2% |
| 2018 | 47.0% | +17.5% |
| 2019 | 54.0% | +14.9% |
| 2020 | 60.0% | +11.1% |
| 2021 | 64.0% | +6.7% |
| 2022 | 70.0% | +9.4% |
| 2023 | 76.0% | +8.6% |
| 2024 | 81.0% | +6.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 3.0% | 10 |
| 2010s | 25.1% | 5.0% | 54.0% | 10 |
| 2020s | 70.2% | 60.0% | 81.0% | 5 |
Countries ranked near Tajikistan
- 49 South Africa 81.0% compare
- 51 Cape Verde 80.0% compare
- 51 Peru 80.0% compare
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Population ages 40-44, male, annual growth rate 5.2 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0272 units per person (2025)
- Population ages 45-49, female, annual growth rate 3.22 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0226 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Tajikistan?
- Share of people with hiv who receive antiretroviral therapy in Tajikistan was 81.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Tajikistan?
- The highest recorded value was 81.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Tajikistan?
- The lowest recorded value was 0.0% in 2000.
- How does Tajikistan rank for share of people with hiv who receive antiretroviral therapy?
- Tajikistan ranks 49th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Tajikistan?
- Over the last ten years it is up 350.0%. The long-run trend across the full record is volatile.
- Where does this Tajikistan data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.